Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer. 1994 Jul 01;74(1):74–7. doi: 10.1002/1097-0142(19940701)74:1<74::aid-cncr2820740113>3.0.co;2-#. PMID: 8004585.